These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 29728089)

  • 1. Update on the types and usage of liquid biopsies in the clinical setting: a systematic review.
    Arneth B
    BMC Cancer; 2018 May; 18(1):527. PubMed ID: 29728089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review.
    Van Paemel R; Vlug R; De Preter K; Van Roy N; Speleman F; Willems L; Lammens T; Laureys G; Schleiermacher G; Tytgat GAM; Astrahantseff K; Deubzer H; De Wilde B
    Eur J Pediatr; 2020 Feb; 179(2):191-202. PubMed ID: 31897843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Biopsies in Oncology and the Current Regulatory Landscape.
    Strotman LN; Millner LM; Valdes R; Linder MW
    Mol Diagn Ther; 2016 Oct; 20(5):429-36. PubMed ID: 27324559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Application of Cancer Molecular Diagnostics with Liquid Biopsy].
    Kubota M
    Rinsho Byori; 2016 Oct; 64(10):1156-1162. PubMed ID: 30609474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Interest of Circulating Tumor DNA in Oncology.
    Franczak C; Filhine-Tressarieu P; Broséus J; Gilson P; Merlin JL; Harlé A
    Arch Med Res; 2018 Jul; 49(5):297-305. PubMed ID: 30414710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
    Ponti G; Manfredini M; Tomasi A
    Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breakthrough Technologies: Liquid Biopsy -Chairmen's Introductory Remarks.].
    Nakatani K; Furuta K
    Rinsho Byori; 2016 May; 64(4):392-393. PubMed ID: 29182804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feasibility of using mutation detection in ctDNA to assess tumor dynamics.
    Yi X; Ma J; Guan Y; Chen R; Yang L; Xia X
    Int J Cancer; 2017 Jun; 140(12):2642-2647. PubMed ID: 28124376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types.
    Hu H; Song H; Han B; Zhao H; He J
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):80. PubMed ID: 38420812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer.
    von Bubnoff N
    Oncol Res Treat; 2017; 40(7-8):409-416. PubMed ID: 28693026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in germ cell tumors: biology and clinical management.
    Chovanec M; Kalavska K; Mego M; Cheng L
    Expert Rev Mol Diagn; 2020 Feb; 20(2):187-194. PubMed ID: 31652083
    [No Abstract]   [Full Text] [Related]  

  • 15. Liquid Biopsy - The Non-invasive Tool for Tracking Cancer.
    Baig S; Jafarey O
    J Coll Physicians Surg Pak; 2018 Jun; 28(6):417-418. PubMed ID: 29848413
    [No Abstract]   [Full Text] [Related]  

  • 16. Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring.
    Martins I; Ribeiro IP; Jorge J; Gonçalves AC; Sarmento-Ribeiro AB; Melo JB; Carreira IM
    Genes (Basel); 2021 Feb; 12(3):. PubMed ID: 33673461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!
    Fontanilles M; Duran-Peña A; Idbaih A
    Curr Neurol Neurosci Rep; 2018 Mar; 18(3):13. PubMed ID: 29520561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies.
    Esposito A; Criscitiello C; Locatelli M; Milano M; Curigliano G
    Pharmacol Ther; 2016 Jan; 157():120-4. PubMed ID: 26615782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Cell-Free Tumour DNA in the Management of Cancer.
    Francis G; Stein S
    Int J Mol Sci; 2015 Jun; 16(6):14122-42. PubMed ID: 26101870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.